Synergistic inhibition of VEGF and modulation of the immune response
US2006014713A1
Immunostimulatory oligonucleotide multimers
EP1729802A2
Enhanced activity of hiv vaccine using a second generation immunomodulatory oligonucleotide
WO2005081847A2
Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
CN1960767A
Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
US2005089915A1
Hybridization-based fluorescence assay
MXPA06000619A
Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy.
CN1852917A
Synergisitic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy
CN1835963A
Stabilized immunomodulatory oligonucleotides
MXPA05013658A
Stabilized immunomodulatory oligonucleotides.
US2005054600A1
Modified protein kinase a-specific oligonucleotides and methods of their use
CN101094594A
Modulation of immunostimulatory properties by small oligonucleotide-based compounds
EP1393745A1
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5'ends
US2003186911A1
Inhibition of infectious agents by exogenous oligonucleotides
US2003191078A1
Inhibition of infectious agents by exogenous oligonucleotides
WO03035836A2
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
US2003125287A1
Antisense oligonucleotides and methods to induce tumor cell death
